Apivas 2.5 Tablet
By Apivas
Rx
10 Tablet in a Strip

Composition
Apixaban(2.5mg)

Manufacturer - Micro Labs Ltd
27, RACE COURSE ROAD, BANGALORE-560 001, INDIA

Expires on or after
June, 2026
About Apivas 2.5 Tablet
Apivas 2.5 Tablet, containing the active ingredient Apixaban, is classified as an anticoagulant medication, commonly referred to as a blood thinner. It is primarily utilized to prevent and treat blood clots in various parts of the body, such as the legs, lungs, brain, and heart. Particularly, Apivas 2.5 Tablet is beneficial for patients with irregular heart rhythms (atrial fibrillation), as it helps in averting the formation of harmful clots. Moreover, individuals who have undergone elective knee or hip replacement surgeries can also benefit from this medication, as it diminishes the risk of clot development in these cases.
It is important to note that Apivas 2.5 Tablet can be taken with or without food, ideally at the same time daily. The duration of intake may vary as prescribed by your physician, and it is crucial not to alter the dose or discontinue usage without proper medical guidance. Abrupt cessation or dosage changes can significantly elevate the risk of severe cardiovascular events, such as heart attacks, strokes, or thrombosis, which is the formation of blood clots within blood vessels.
While consuming Apivas 2.5 Tablet, there is an increased likelihood of bleeding more easily than usual, leading to symptoms like nosebleeds or bruising. Should any adverse reactions occur, it is imperative to promptly notify your healthcare provider. Furthermore, potential side effects also encompass hematoma, anemia, and nausea. Notably, individuals with severe kidney or liver ailments, those actively bleeding, or those concurrently taking other blood-thinning medications should avoid Apivas 2.5 Tablet. Moreover, it is advised against breastfeeding while using this medication.
Distinct from some other anticoagulants, regular monitoring through blood tests, specifically the Prothrombin Time-International Normalized Ratio (PT-INR) test, is not obligatory while undergoing treatment with Apivas 2.5 Tablet. This medication plays a critical role in managing conditions like deep vein thrombosis and pulmonary embolism, among others, by inhibiting the action of a crucial blood clotting factor. Always adhere to your doctor's instructions regarding the administration of Apivas 2.5 Tablet and report any concerning symptoms promptly.
Disclaimer
The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.
₹148.5
₹165
10% OFF
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024
